(Q36400947)

14 August 2017

Clinical effects of long-term metreleptin treatment in patients with lipodystrophy (English)

1 reference

14 August 2017

Jean L Chan

1

1 reference

14 August 2017

Karen Lutz

2

1 reference

14 August 2017

Elaine Cochran

3

1 reference

14 August 2017

Wenying Huang

4

1 reference

14 August 2017

Yvette Peters

5

1 reference

14 August 2017

Christian Weyer

6

1 reference

14 August 2017

Phillip Gorden

7

1 reference

14 August 2017

language of work or name

1 reference

1 November 2011

1 reference

14 August 2017

1 reference

14 August 2017

17

1 reference

14 August 2017

6

1 reference

14 August 2017

922-932

1 reference

Is there a human model for the 'metabolic syndrome' with a defined aetiology?

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Clinical classification and treatment of congenital and acquired lipodystrophy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Acquired and inherited lipodystrophies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Site and mechanism of leptin action in a rodent form of congenital lipodystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

30 September 2017

Lipoatrophy revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Regulation of fatty acid homeostasis in cells: novel role of leptin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Efficacy of leptin therapy in the different forms of human lipodystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Long-term efficacy of leptin replacement in patients with generalized lipodystrophy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Serum adiponectin and leptin levels in patients with lipodystrophies

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Leptin-replacement therapy for lipodystrophy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3498767

21 September 2018

Identifiers

DOI

10.4158/EP11229.OR

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22068254

1 reference